50% effective concentration of sevoflurane for immobility in cerebral palsy children undergoing botulinum toxin
Kanghui Kim1, Eunhee Lee, Sung Mee Jung
1Department of Anesthesiology and Pain Medicine, Yeungnam University College of Medicine, Daegu, Republic of Korea.
Insights
The optimal end-tidal sevoflurane concentration for immobile botulinum toxin injections in children with cerebral palsy (CP) is 1.76%. This concentration ensures successful procedures in 50% of pediatric patients undergoing treatment.
Area of Science:
- Anesthesiology
- Pediatric Medicine
- Neurology
Background:
- Cerebral palsy (CP) affects children's motor functions, often necessitating treatments like botulinum toxin injections.
- Immobility is crucial for the success of botulinum toxin injections, especially in pediatric patients.
Purpose of the Study:
- To determine the optimal end-tidal sevoflurane concentration for achieving immobility during botulinum toxin injections.
- To establish the effective concentration (EC50) of sevoflurane for this specific pediatric procedure.
Main Methods:
- A prospective study involving 23 children (aged 3-12 years) with spastic CP.
- Modified Dixon's up-and-down method was used to determine end-tidal sevoflurane concentration for immobility.
- Botulinum toxin type A injections were administered to spontaneously breathing children under sevoflurane sedation.
Main Results:
- The 50% effective end-tidal concentration (EC50) of sevoflurane for immobility was found to be 1.76% ± 0.15%.
- Probit analysis predicted EC50 at 1.77% and the 95% effective concentration (EC95) at 2.09% for immobility.
- 57.1% of the children achieved "no movement" during the injection at the determined concentrations.
Conclusions:
- Botulinum toxin injections can be safely and effectively performed in spontaneously breathing children with CP using a specific sevoflurane concentration.
- An end-tidal sevoflurane concentration of 1.76% ± 0.15% is effective for achieving immobility in 50% of pediatric patients with CP undergoing botulinum toxin injections.
Background:
This prospective study aimed to determine the optimum end-tidal sevoflurane concentration required for immobility during botulinum toxin injection in spontaneously breathing children with cerebral palsy (CP).
Methods:
Twenty-three children with spastic CP, aged 3 to 12 years, with American Society of Anesthesiologists (ASA) physical status I and II, scheduled to receive botulinum toxin type A injection were enrolled in the study. After induction of deep sedation using pre-filled 8% sevoflurane in oxygen and maintenance of the predetermined end-tidal sevoflurane concentration, the botulinum toxin was injected in spontaneously breathing children. The response to the botulinum toxin injection was classified as "movement" or "no movement" by an independent investigator who was blinded to the predetermined end-tidal sevoflurane concentration and bispectral index (BIS) value. The end-tidal sevoflurane concentration was predetermined, initiating at 2.0% with 0.2% as a step size in the next patient depending on the previous patient's response using the modified Dixon's up-and-down method.
Results:
Of 21 children, 12 (57.1%) showed "no movement" in response to the botulinum toxin injection. By Dixon's up-and-down method, the 50% effective end-tidal concentration (EC50) of sevoflurane for successful botulinum toxin injection was 1.76 ± 0.15% (95% CI 1.62-1.90). Based on the dose-response curve using probit analysis, the predicted EC50 and 95% effective end-tidal concentrations (EC95) of sevoflurane without movement were 1.77% (95% CI 1.59-2.35) and 2.09% (95% CI 1.89-5.80), respectively.
Conclusion:
Botulinum toxin injection can be successfully accomplished at an end-tidal sevoflurane concentration of 1.76 ± 0.15% in 50% of spontaneously breathing children with CP aged 3-12 years.
More Related Videos
08:49Assessing Changes in Volatile General Anesthetic Sensitivity of Mice after Local or Systemic Pharmacological Intervention
Published on: October 16, 2013
04:56In Vitro Method to Control Concentrations of Halogenated Gases in Cultured Alveolar Epithelial Cells
Published on: October 23, 2018
Related Concept Videos
Depolarizing Blockers: Pharmocokinetics
Skeletal Muscle Relaxants: Therapeutic Uses
Parenteral Anesthetics: Overview
Local Anesthetics: Clinical Application as Spinal Anesthesia
Inhalational Anesthetics: Overview
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
